Advair Diskus (fluticasone propionate/salmeterol inhalation powder) — Cigna
Emphysema
Initial criteria
- For Asthma/Reactive Airway Disease, approve for 1 year.
- For Chronic Obstructive Pulmonary Disease, approve for 1 year.
- For Chronic Bronchitis, approve for 1 year.
- For Emphysema, approve for 1 year.
- For Postinfectious Cough, approve for 2 months. Note: Postinfectious cough is cough that persists after an acute respiratory infection has resolved.
Approval duration
1 year (Asthma, COPD, Chronic Bronchitis, Emphysema); 2 months (Postinfectious Cough)